Results for 'COVID-19'
How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
Paul Ward, Oncology MSLs, AstraZeneca, MSL Society, Covid-19 impact on MSLs
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success. In this epi…
May 12th • 41 mins listen
The Future of KOL Engagement and new strategies that will emerge
MSL role, KOL engagement, COVID-19 adjustments, virtual engagement, scientific congresses
In this episode, Joan Cannon shares her journey into the MSL role and the operational shifts faced during the COVID-19 pandemic. The conversation covers adjustments in performance metrics, face-to-face interaction guidelines, and virtual engagement with KOLs. Joan provides insights into the evo…
Oct 20th • 32 mins listen
The MANY ways COVID-19 has made Medical Affairs and MSLs BETTER
medical affairs, virtual engagement, MSL roles, KOL relationships, COVID-19 impact
In this episode, JR Ryskala and Petrina Pellet join Tom Caravela to explore the evolving landscape of medical affairs amidst a shift to virtual engagement. The discussion covers the benefits and challenges of virtual interactions and examines how MSL roles and skillsets are adapting post-pandem…
Feb 23rd • 31 mins listen
How to “Manage Up” and work successfully with your supervisor
Medical Affairs, Manage Up, MSL Metrics, Effective Communication, COVID-19 Adaptability
In this episode, Tom Caravela is joined by Kathleen Quindon to explore the concept of managing up within the field of medical affairs. Kathleen shares insights from her career, emphasizing the importance of balancing quality and quantity in MSL metrics, particularly in the context of COVID-19. …
Jun 15th • 27 mins listen
New ‘Social’ Technology to Help Identify KEY Trends for Medical Affairs
Google Trends, COVID-19 research, medical affairs, pharmaceutical analysis, social arbitrage
In this episode, Tom Caravela is joined by Tim Bialekki and Alec McCarthy to explore the intersection of Google Trends and the MSL role. The discussion delves into how Google Trends can be utilized in COVID-19 research and its implications for medical affairs and pharmaceutical analysis. The sp…
Jul 20th • 35 mins listen
Digital Therapeutics: Everything You Need to Know
Digital Therapeutics, Medical Science Liaison, COVID-19 technology adaptation, opportunities in tech for MSLs, future of Digital Therapeutics
In this episode, Tom Caravela welcomes Madleine Makori to discuss her career journey and passion for the MSL role, with a particular focus on digital therapeutics. Madleine shares insights into the differentiation and challenges of digital therapeutics and how COVID-19 has accelerated technolog…
Feb 1st • 38 mins listen
Coronavirus (COVID-19): Its Impact on Publication Planning (04/29/2020)
COVID-19 impact on medical publishing, virtual congresses and conferences, challenges in medical publications, pandemic effect on scientific journals
The Coronavirus (COVID-19) pandemic has impacted nearly every facet of our personal and professional lives. Medical publication professionals are facing uncharted territory and uncertainty as to how long the impact will last.With live congresses being canceled, postponed or transitioned to a virtual…
Apr 20th • 90 mins listen
Best Practices and Creative Ways to Gain KOL Access During COVID-19
Provide 5 SEO Keywords separated by commas
In this episode, Tom Caravela speaks with Jason Demuth about his journey from retail pharmacy to the pharmaceutical industry. Jason shares his experiences engaging Key Opinion Leaders (KOLs) during COVID, emphasizing the strategic use of social media and email communication. The discussion expl…
Oct 13th • 31 mins listen
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Monoclonal Antibodies to Treat Cancer and COVID-19
ONS member Donna Bydlon, BSN, RN, OCN®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing co…
Jul 15th • 27 mins listen